Trade Arcus Biosciences, Inc. - RCUS CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.15 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023512% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.00129% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 13.06 |
| Open | 13.13 |
| 1-Year Change | -13.05% |
| Day's Range | 13.13 - 13.63 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jan 24, 2025 | 13.06 | -0.09 | -0.68% | 13.15 | 13.44 | 12.89 |
| Jan 23, 2025 | 13.21 | 0.04 | 0.30% | 13.17 | 13.48 | 12.80 |
| Jan 22, 2025 | 13.29 | -0.68 | -4.87% | 13.97 | 14.02 | 13.29 |
| Jan 21, 2025 | 14.09 | 0.10 | 0.71% | 13.99 | 14.27 | 13.95 |
| Jan 17, 2025 | 13.88 | -0.25 | -1.77% | 14.13 | 14.18 | 13.88 |
| Jan 16, 2025 | 14.02 | -0.04 | -0.28% | 14.06 | 14.22 | 13.74 |
| Jan 15, 2025 | 14.11 | 0.08 | 0.57% | 14.03 | 14.43 | 13.87 |
| Jan 14, 2025 | 13.67 | -0.14 | -1.01% | 13.81 | 13.97 | 13.55 |
| Jan 13, 2025 | 13.87 | 0.11 | 0.80% | 13.76 | 13.93 | 13.34 |
| Jan 10, 2025 | 14.14 | -0.37 | -2.55% | 14.51 | 14.53 | 13.65 |
| Jan 8, 2025 | 14.88 | -0.09 | -0.60% | 14.97 | 15.25 | 14.78 |
| Jan 7, 2025 | 15.19 | 0.47 | 3.19% | 14.72 | 15.52 | 14.72 |
| Jan 6, 2025 | 14.77 | -0.08 | -0.54% | 14.85 | 15.33 | 14.50 |
| Jan 3, 2025 | 14.90 | -0.08 | -0.53% | 14.98 | 15.45 | 14.90 |
| Jan 2, 2025 | 15.05 | 0.29 | 1.96% | 14.76 | 15.51 | 14.69 |
| Dec 31, 2024 | 14.75 | 0.07 | 0.48% | 14.68 | 15.07 | 14.55 |
| Dec 30, 2024 | 14.80 | -0.07 | -0.47% | 14.87 | 15.09 | 14.49 |
| Dec 27, 2024 | 15.12 | -0.34 | -2.20% | 15.46 | 15.65 | 14.88 |
| Dec 26, 2024 | 15.74 | 0.30 | 1.94% | 15.44 | 15.97 | 15.44 |
| Dec 24, 2024 | 15.79 | 0.32 | 2.07% | 15.47 | 15.88 | 15.36 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Arcus Biosciences, Inc. Company profile
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing cancer therapies in the United States. The company''s product pipeline includes, AB928, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 monoclonal antibody that is in Phase Ib clinical trial for monotherapy. It is also developing AB154, an anti-TIGIT monoclonal antibody, which is in Phase 2 development for the treatment of first-line metastatic non-small cell lung cancer in combination with Zimberelimab and AB928; and AB680, small-molecule CD73 inhibitor is in a Phase 1/1b study for the treatment of first-line metastatic pancreatic cancer. Arcus Biosciences, Inc. has a clinical development collaboration agreement with Strata Oncology, Inc. to evaluate Zimberelimab; license agreements with Taiho Pharmaceutical Co., Ltd, Abmuno Therapeutics LLC, and WuXi Biologics (Cayman) Inc.; and co-development and co-commercialization partnership with Gilead Sciences, Inc. for the development of cancer immunotherapies. The company was founded in 2015 and is based in Hayward, California.| Industry: | Biotechnology & Medical Research (NEC) |
3928 Point Eden Way
HAYWARD
CALIFORNIA 94545-3719
US
News
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
12:40, 31 December 2024
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com